-
10006486-500A synthetic analog of 17&beta-estradiol
-
10006486-5000A synthetic analog of 17&beta-estradiol
-
15999-10A positive allosteric modulator of GABAA receptors that produces anxiolytic effects by preferentially modulating GABAA receptors containing &beta2 or &beta3 subunits (EC<sub>50</sub>s = 7.5 µM) over those bearing a &beta1 subunit
-
15999-25A positive allosteric modulator of GABAA receptors that produces anxiolytic effects by preferentially modulating GABAA receptors containing &beta2 or &beta3 subunits (EC<sub>50</sub>s = 7.5 µM) over those bearing a &beta1 subunit
-
15999-5A positive allosteric modulator of GABAA receptors that produces anxiolytic effects by preferentially modulating GABAA receptors containing &beta2 or &beta3 subunits (EC<sub>50</sub>s = 7.5 µM) over those bearing a &beta1 subunit
-
15999-50A positive allosteric modulator of GABAA receptors that produces anxiolytic effects by preferentially modulating GABAA receptors containing &beta2 or &beta3 subunits (EC<sub>50</sub>s = 7.5 µM) over those bearing a &beta1 subunit
-
12092-100An inhibitor of topoisomerase II (IC<sub>50</sub> = 60.3 &muM) can have much greater potencies when evaluated in cell-based cytotoxicity assays (e.
-
12092-25An inhibitor of topoisomerase II (IC<sub>50</sub> = 60.3 &muM) can have much greater potencies when evaluated in cell-based cytotoxicity assays (e.
-
12092-50An inhibitor of topoisomerase II (IC<sub>50</sub> = 60.3 &muM) can have much greater potencies when evaluated in cell-based cytotoxicity assays (e.
-
12092-500An inhibitor of topoisomerase II (IC<sub>50</sub> = 60.3 &muM) can have much greater potencies when evaluated in cell-based cytotoxicity assays (e.
-
10091-10A dipyridinyl compound that demonstrates high in vitro and ex vivo selectivity for COX-2 over COX-1.
-
10091-100A dipyridinyl compound that demonstrates high in vitro and ex vivo selectivity for COX-2 over COX-1.